These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7380954)

  • 1. Determination of adriamycin and daunorubicin in urine by high-performance liquid chromatography with laser fluorometric detection.
    Sepaniak MJ; Yeung ES
    J Chromatogr; 1980 Apr; 190(2):377-83. PubMed ID: 7380954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of rubidazone and its metabolites in human plasma and urine by reversed-phase ion-pair high-performance liquid chromatography.
    Nguyen-Huu JJ; Turk P; Diquet B
    J Chromatogr; 1986 Aug; 380(2):455-61. PubMed ID: 3760077
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):11-4. PubMed ID: 498412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous extraction of urinary anthracycline antitumor antibiotics with the horizontal flow-through coil planet centrifuge.
    Nakazawa H; Riggs CE; Egorin MJ; Redwood SM; Bachur NR; Bhatnagar R; Ito Y
    J Chromatogr; 1984 May; 307(2):323-33. PubMed ID: 6588053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C; Rinaldi P; Leoni E; Poggi G; Teragni C; Delmonte A; Minoia C
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2645-59. PubMed ID: 18666202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection.
    Akpofure C; Riley CA; Sinkule JA; Evans WE
    J Chromatogr; 1982 Nov; 232(2):377-83. PubMed ID: 7153284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
    Maliszewska O; Plenis A; Olędzka I; Kowalski P; Miękus N; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
    J Pharm Biomed Anal; 2018 Sep; 158():376-385. PubMed ID: 29936377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Pierce RN; Jatlow PI
    J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.
    Eksborg S; Ehrsson H; Andersson B; Beran M
    J Chromatogr; 1978 Jun; 153(1):211-8. PubMed ID: 659557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
    Cummings J; Stuart JF; Calman KC
    J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
    Wiernik PH
    Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitation of daunorubicin, doxorubicin, and their aglycones by ion-pair reversed-phase chromatography.
    Haneke AC; Crawford J; Aszalos A
    J Pharm Sci; 1981 Oct; 70(10):1112-5. PubMed ID: 7299643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser-excited atomic fluorescence in a flame as a high-sensitivity detector for organomanganese and organotin compounds following separation by high-performance liquid chromatography.
    Walton AP; Wei GT; Liang Z; Michel RG; Morris JB
    Anal Chem; 1991 Feb; 63(3):232-40. PubMed ID: 1824009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of doxorubicin photodegradation in plasma, urine and cell culture medium by HPLC.
    Le Bot MA; Riche C; Guedes Y; Kernaleguen D; Simon S; Begue JM; Berthou F
    Biomed Chromatogr; 1988 Nov; 2(6):242-4. PubMed ID: 3233392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel.
    Sottani C; Tranfo G; Bettinelli M; Faranda P; Spagnoli M; Minoia C
    Rapid Commun Mass Spectrom; 2004; 18(20):2426-36. PubMed ID: 15386628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.
    Eksborg S
    J Chromatogr; 1978 Feb; 149():225-32. PubMed ID: 649731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
    Davis HL; Davis TE
    Cancer Treat Rep; 1979 May; 63(5):809-15. PubMed ID: 378369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.